Photo of Eric Alexander

For as long as we have been representing drug and device companies in product liability litigation, the plaintiffs have accused our clients of “buying the science.”  Sometimes, this has allegedly been by funding studies or offering support to outside researchers such as free product or access to administrative support.  Sometimes, this has allegedly been by

Photo of Steven Boranian

We have become accustomed to doing things remotely these days.  Depositions, court appearances, mediations, conferences, celebrations and family gatherings of all kinds.  The variety of activities that we now do by videoconference pales only by comparison to the speed with which we adapted to this new normal.  We will refrain from opining on whether we